Published in Biol Psychiatry on December 15, 1996
Effects of antipsychotics on the inflammatory response system of patients with schizophrenia in peripheral blood mononuclear cell cultures. Clin Psychopharmacol Neurosci (2013) 0.96
Association study of interleukin 2 (IL2) and IL4 with schizophrenia in a Japanese population. Eur Arch Psychiatry Clin Neurosci (2008) 0.78
Cytokines in schizophrenia. Biol Psychiatry (1997) 0.76
Inflammation in Schizophrenia: Cytokine Levels and Their Relationships to Demographic and Clinical Variables. Am J Geriatr Psychiatry (2016) 0.75
Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Mol Psychiatry (2008) 3.85
Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature (1982) 3.26
Antiviral effects of recombinant tumour necrosis factor in vitro. Nature (1986) 3.25
The immunobiology of zinc. Immunol Today (1997) 2.93
High incidence of active cytomegalovirus infection among septic patients. Clin Infect Dis (1998) 2.48
Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology (2000) 2.46
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry (2006) 2.44
Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus. J Exp Med (1974) 2.40
An international two-stage genome-wide search for schizophrenia susceptibility genes. Nat Genet (1995) 2.26
Splenic suppressor macrophages induced in mice by injection of Corynebacterium parvum. J Immunol (1975) 2.13
Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). J Clin Oncol (2004) 2.07
Interferon-gamma production by Listeria monocytogenes-specific T cells active in cellular antibacterial immunity. Eur J Immunol (1983) 2.06
Home therapy with recombinant interleukin-2 and interferon-alpha 2b in advanced human malignancies. Lancet (1990) 1.80
Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma. J Natl Cancer Inst (1996) 1.79
Defining the human hippocampus in cerebral magnetic resonance images--an overview of current segmentation protocols. Neuroimage (2009) 1.68
Low ferritin levels indicate the need for iron supplementation: strategy to minimize iron-depletion in regular blood donors. Transfus Med (2000) 1.67
Detection and quantification of latently infected B lymphocytes in Epstein-Barr virus-seropositive, healthy individuals by polymerase chain reaction. J Clin Microbiol (1992) 1.66
Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice. J Immunol (1975) 1.62
Failure to detect human cytomegalovirus DNA in peripheral blood leukocytes of healthy blood donors by the polymerase chain reaction. Transfusion (1992) 1.60
Multiinstitutional home-therapy trial of recombinant human interleukin-2 and interferon alfa-2 in progressive metastatic renal cell carcinoma. J Clin Oncol (1995) 1.58
Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol Scand (1988) 1.57
Interferon treatment inhibits onset of herpes simplex virus immediate-early transcription. Virology (1988) 1.55
Interleukin-2 based home therapy of metastatic renal cell carcinoma: risks and benefits in 215 consecutive single institution patients. J Urol (1996) 1.55
Two functionally distinct anti-tumor effector cells isolated from primary murine sarcoma virus-induced tumors. J Immunol (1976) 1.53
Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2. Ann Oncol (1992) 1.50
Altered cytokine production in the elderly. Mech Ageing Dev (1998) 1.47
Polyclonal immunoglobulin secretion by human B lymphocytes exposed to Epstein-Barr virus in vitro. J Immunol (1979) 1.46
Production of immune interferon by murine T-cell clones from long-term cultures. Nature (1981) 1.45
Conjugated estrogen reduces transfusion and coagulation factor requirements in orthotopic liver transplantation. Anesth Analg (1998) 1.43
IL-2 in combination with IFN- alpha and 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial. Br J Cancer (2001) 1.42
[An interuniversity comparison of the supervision of doctoral candidates--should the promotion procedures be changed?]. Dtsch Med Wochenschr (2000) 1.40
Adenoviral vector infection of the human exocrine pancreas. Arch Surg (1997) 1.38
Maternal posttraumatic stress response after the birth of a very low-birth-weight infant. J Psychosom Res (2004) 1.37
Coincidence of neonatal alloimmune thrombocytopenia and maternal anti-D immunization: case report. Br J Haematol (1998) 1.37
Detection of facial expressions of emotions in depression. Percept Mot Skills (2001) 1.35
The detection of human cytomegalovirus immediate early antigen in peripheral blood leucocytes. J Immunol Methods (1991) 1.35
The influence of naturally occurring heterophilic anti-immunoglobulin antibodies on direct measurement of serum proteins using sandwich ELISAs. J Immunol Methods (2000) 1.34
Kinetics of the Zn 2+ - stimulation of human peripheral lmphocytes in vitro. Proc Soc Exp Biol Med (1971) 1.34
Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1-specific memory cytotoxic T lymphocytes. J Immunol (1985) 1.28
Genetic variability of herpes simplex virus: development of a pathogenic variant during passaging of a nonpathogenic herpes simplex virus type 1 virus strain in mouse brain. J Virol (1983) 1.27
Review of immunological and immunopathological findings in schizophrenia. Brain Behav Immun (2001) 1.27
Antiviral activity of tumour necrosis factor. Synergism with interferons and induction of oligo-2',5'-adenylate synthetase. J Gen Virol (1988) 1.26
Serotonergic genes modulate amygdala activity in major depression. Genes Brain Behav (2006) 1.25
Experimental infection of inbred mice with herpes simplex virus type 1. I. Investigation of humoral and cellular immunity and of interferon induction. J Gen Virol (1981) 1.25
COMPRI--an instrument to detect patients with complex care needs: results from a European study. Psychosomatics (2001) 1.25
Failure to detect antiviral activity in serum and plasma of healthy individuals displaying high activity in ELISA for IFN-alpha and IFN-beta. J Interferon Cytokine Res (1999) 1.24
Neural correlates of trait anxiety in fear extinction. Psychol Med (2010) 1.24
In vitro mitogenic stimulation of murine spleen cells by herpes simplex virus. J Immunol (1978) 1.24
Replication of herpes simplex virus in human T lymphocytes: characterization of the viral target cell. J Immunol (1984) 1.24
Zinc-altered immune function and cytokine production. J Nutr (2000) 1.22
The effects of general anesthesia on human peripheral immune cell distribution and cytokine production. Clin Immunol Immunopathol (1997) 1.21
Prostaglandin synthesis in spleen cell cultures of mice injected with Corynebacterium parvum. Cell Immunol (1978) 1.20
Functional anatomy of visuo-spatial working memory during mental rotation is influenced by sex, menstrual cycle, and sex steroid hormones. Neuropsychologia (2007) 1.19
Human cytomegalovirus replicates in primary human bone marrow cells. J Gen Virol (1986) 1.18
Cytokine production and serum proteins in depression. Scand J Immunol (1995) 1.18
Mycophenolate mofetil in pediatric renal transplantation. Pediatr Transplant (1999) 1.18
Experimental infection of inbred mice with herpes simplex virus. V. Investigations with a virus strain non-lethal after peripheral infection. J Gen Virol (1982) 1.18
Rapid HLA-DRB1 genotyping by nested PCR amplification. Tissue Antigens (1992) 1.16
Pokeweed mitogen-, concanavalin A-, and phytohemagglutinin-induced development of cytotoxic effector lymphocytes. An evaluation of the mechanisms of T cell-mediated cytotoxicity. J Exp Med (1973) 1.16
The role of interferon in the resistance of C57BL/6 mice to various doses of herpes simplex virus type 1. J Infect Dis (1982) 1.16
Inhibition of the mixed lymphocyte culture by peritoneal exudate cells. Cell Immunol (1976) 1.15
Stimulation of chicken lymphocytes in a serum-free medium. Cell Immunol (1972) 1.15
Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression. Psychol Med (2003) 1.14
Mycoplasma contamination in human tumor cell lines: effect on interferon induction and susceptibility to natural killing. J Immunol (1981) 1.13
A combined functional in vivo measure for primary and secondary auditory cortices. Hear Res (2000) 1.11
Neuropeptide S receptor gene -- converging evidence for a role in panic disorder. Mol Psychiatry (2010) 1.09
Dysregulation between TH1 and TH2 T cell subpopulations in the elderly. Mech Ageing Dev (1996) 1.08
Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF. Mol Psychiatry (2004) 1.08
An X-linked locus influences the amount of circulating interferon induced in the mouse by herpes simplex virus type 1. J Gen Virol (1982) 1.08
Clonal analysis of human T cell activation by the Mycoplasma arthritidis mitogen (MAS). Eur J Immunol (1988) 1.08
A reappraisal of the effector cells mediating mitogen induced cellular cytotoxicity. Cell Immunol (1975) 1.08
Inflammatory markers in major depression and melancholia. J Affect Disord (2001) 1.07
Cytomegalovirus transcripts in peripheral blood leukocytes of actively infected transplant patients detected by reverse transcription-polymerase chain reaction. J Infect Dis (1993) 1.07
Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial. Ann Oncol (2008) 1.06
Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology. Mol Psychiatry (2001) 1.05
Inhibition of in vitro lymphoproliferative responses to tumor-associated antigens by suppressor cells from rats bearing progressively growing Gross leukemia virus-induced tumors. Int J Cancer (1975) 1.05
Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for posttransplant lymphoproliferative disorders. J Clin Microbiol (2001) 1.05
Kinetics and organ distribution of allogeneic natural killer lymphocytes transfused into patients suffering from renal cell carcinoma. Stem Cells Dev (2004) 1.04
Coincidence of Epstein-Barr virus reactivation, cytomegalovirus infection, and rejection episodes in renal transplant recipients. Transplantation (1995) 1.04
Protection against herpes simplex virus infection in mice by Corynebacterium parvum. Infect Immun (1977) 1.04
Stimulation of human peripheral lymphocytes by Zn2+ in vitro. Exp Cell Res (1970) 1.04
Recent progress in the tumor necrosis factor-alpha field. Int Arch Allergy Immunol (1996) 1.03
Prognostic impact of in vivo soluble cell adhesion molecules in metastatic renal cell carcinoma. Br J Cancer (1999) 1.03
A whole-blood technique for testing production of human interferon by leukocytes. J Immunol Methods (1982) 1.03
Care complexity in the general hospital: results from a European study. Psychosomatics (2001) 1.03
Human peripheral null lymphocytes. II. Producers of type-1 interferon upon stimulation with tumor cells, Herpes simplex virus and Corynebacterium parvum. Eur J Immunol (1980) 1.02
Experimental infection of inbred mice with herpes simplex virus. II. Interferon production and activation of natural killer cells in the peritoneal exudate. J Gen Virol (1981) 1.02
Mucosal cytokine expression, cellular markers and adhesion molecules in inflammatory bowel disease. Eur J Gastroenterol Hepatol (1999) 1.02
Production of immune interferon is regulated by more than T cell subset: Lyt-1,2,3 and Qat-5 phenotypes of murine T lymphocytes involved in IFN-gamma production in primary and secondary mixed lymphocyte reaction. Eur J Immunol (1982) 1.02
Production of an antiviral factor by murine spleen cells after treatment with Corynebacterium parvum. Cell Immunol (1977) 1.02
Long-term cognitive and emotional consequences of mild traumatic brain injury. Psychol Med (2010) 1.02
Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations. Transfusion (2000) 1.02
Cytokine production after helium-neon laser irradiation in cultures of human peripheral blood mononuclear cells. J Photochem Photobiol B (1992) 1.01
Elevated plasma levels of S-100b protein in schizophrenic patients. Biol Psychiatry (1999) 1.01
Biochemotherapy of advanced metastatic renal-cell carcinoma: results of the combination of interleukin-2, alpha-interferon, 5-fluorouracil, vinblastine, and 13-cis-retinoic acid. World J Urol (1995) 1.01
A human whole-blood assay for analysis of T-cell function by quantification of cytokine mRNA. Scand J Immunol (1999) 1.01